David McErlane, Group President, Biologics at Catalent, Inc. (CTLT), sold 3,988 shares at $59.97 ($239K) on 2024-09-26, disclosed to the SEC on 2024-09-27.
Open-market sale of $239k CTLT by Group President, Biologics. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.97 | 1,994 | $120K | 50.0% |
| 2 | $59.97 | 1,994 | $120K | 50.0% |
| Total | $59.97 avg | 3,988 | $239K | 100% |